77 related articles for article (PubMed ID: 26486970)
1. Coordinated Priming of NKG2D Pathway by IL-15 Enhanced Functional Properties of Cytotoxic CD4
Wang T; Wei L; Meng S; Song W; Chen Y; Li H; Zhao Q; Jiang Z; Liu D; Ren H; Hong X
Inflammation; 2023 Oct; 46(5):1587-1601. PubMed ID: 37415045
[TBL] [Abstract][Full Text] [Related]
2. The signature and predictive value of immune parameters in patients with secondary hemophagocytic lymphohistiocytosis.
Bai H; Wang Y; Shen L; Luo Y; Tang G; Wang F; Sun Z; Hou H
Immunobiology; 2023 Nov; 228(6):152759. PubMed ID: 37939638
[TBL] [Abstract][Full Text] [Related]
3. Enhancing cancer immunotherapy with Anti-NKG2D/IL-15(N72D)/Sushi fusion protein: Targeting cytotoxic immune cells and boosting IL-15 efficacy.
Ahmadi N; Zareinejad M; Ameri M; Mahmoudi Maymand E; Nooreddin Faraji S; Ghaderi A; Ramezani A
Cytokine; 2024 Apr; 176():156505. PubMed ID: 38301357
[TBL] [Abstract][Full Text] [Related]
4. Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.
Pasero C; Gravis G; Guerin M; Granjeaud S; Thomassin-Piana J; Rocchi P; Paciencia-Gros M; Poizat F; Bentobji M; Azario-Cheillan F; Walz J; Salem N; Brunelle S; Moretta A; Olive D
Cancer Res; 2016 Apr; 76(8):2153-65. PubMed ID: 27197252
[TBL] [Abstract][Full Text] [Related]
5. Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer.
Rocha Martins P; Luciano Pereira Morais K; de Lima Galdino NA; Jacauna A; Paula SOC; Magalhães WCS; Zuccherato LW; Campos LS; Salles PGO; Gollob KJ
Sci Rep; 2023 Dec; 13(1):22634. PubMed ID: 38114557
[TBL] [Abstract][Full Text] [Related]
6. Senescent T cells: Beneficial and detrimental roles.
Laphanuwat P; Gomes DCO; Akbar AN
Immunol Rev; 2023 Jul; 316(1):160-175. PubMed ID: 37098109
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities.
Avila JP; Carvalho BM; Coimbra EC
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831674
[TBL] [Abstract][Full Text] [Related]
8. CMTM6 as a candidate risk gene for cervical cancer: Comprehensive bioinformatics study.
Huang X; Liu W; Liu C; Hu J; Wang B; Ren A; Huang X; Yuan Y; Liu J; Li M
Front Mol Biosci; 2022; 9():983410. PubMed ID: 36589225
[No Abstract] [Full Text] [Related]
9. Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment.
Zhu S; Wang Y; Tang J; Cao M
Front Immunol; 2022; 13():1074477. PubMed ID: 36532071
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Wang X; Tang W; Lu Y; You J; Han Y; Zheng Y
Int J Gen Med; 2021; 14():7933-7949. PubMed ID: 34785939
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Herrera FG; Ronet C; Ochoa de Olza M; Barras D; Crespo I; Andreatta M; Corria-Osorio J; Spill A; Benedetti F; Genolet R; Orcurto A; Imbimbo M; Ghisoni E; Navarro Rodrigo B; Berthold DR; Sarivalasis A; Zaman K; Duran R; Dromain C; Prior J; Schaefer N; Bourhis J; Dimopoulou G; Tsourti Z; Messemaker M; Smith T; Warren SE; Foukas P; Rusakiewicz S; Pittet MJ; Zimmermann S; Sempoux C; Dafni U; Harari A; Kandalaft LE; Carmona SJ; Dangaj Laniti D; Irving M; Coukos G
Cancer Discov; 2022 Jan; 12(1):108-133. PubMed ID: 34479871
[TBL] [Abstract][Full Text] [Related]
12. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4
Meckiff BJ; Ladell K; McLaren JE; Ryan GB; Leese AM; James EA; Price DA; Long HM
J Immunol; 2019 Sep; 203(5):1276-1287. PubMed ID: 31308093
[TBL] [Abstract][Full Text] [Related]
13. Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
Barros MR; de Oliveira THA; de Melo CML; Venuti A; de Freitas AC
J Immunol Res; 2018; 2018():2912671. PubMed ID: 29854832
[TBL] [Abstract][Full Text] [Related]
14. Regulatory NK1.1
Lin Z; Han S; Qian X; Hu C; Xiao W; Qian L; Zhang Y; Ding Y; Jia X; Zhu G; Gong W
Cancer Immunol Immunother; 2018 Jul; 67(7):1159-1173. PubMed ID: 29802426
[TBL] [Abstract][Full Text] [Related]
15. The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.
Stojanovic A; Correia MP; Cerwenka A
Front Immunol; 2018; 9():827. PubMed ID: 29740438
[TBL] [Abstract][Full Text] [Related]
16. NK1.1
Qian X; Hu C; Han S; Lin Z; Xiao W; Ding Y; Zhang Y; Qian L; Jia X; Zhu G; Gong W
J Cell Mol Med; 2017 Jul; 21(7):1431-1444. PubMed ID: 28224733
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?
Juno JA; van Bockel D; Kent SJ; Kelleher AD; Zaunders JJ; Munier CM
Front Immunol; 2017; 8():19. PubMed ID: 28167943
[TBL] [Abstract][Full Text] [Related]
18. An approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma.
Garcia-Chagollan M; Jave-Suarez LF; Haramati J; Bueno-Topete MR; Aguilar-Lemarroy A; Estrada-Chavez C; Bastidas-Ramirez BE; Pereira-Suarez AL; Del Toro-Arreola S
J Biomed Sci; 2015 Oct; 22():91. PubMed ID: 26486970
[TBL] [Abstract][Full Text] [Related]
19. Loss of CD28 within CD4
Escarra-Senmarti M; Bueno-Topete MR; Jave-Suarez LF; Gomez-Bañuelos E; Gutierrez-Franco J; Vega-Magaña N; Aguilar-Lemarroy A; Pereira-Suarez AL; Haramati J; Del Toro-Arreola S
Immunol Lett; 2017 Feb; 182():30-38. PubMed ID: 28087292
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
